At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Hypofractionated Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study Evaluating Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
In Brief
A clinical study evaluating Hypofractionated Radiation Therapy for Soft Tissue Sarcoma. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This is a nonrandomized Phase II pilot protocol to determine the feasibility, toxicity and disease control (local control, overall and progression-free survival) using hypofractionated preoperative radiation therapy in patients with primary localized soft tissue sarcomas (STS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSoft Tissue Sarcoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartFeb 2016
Primary CompletionMay 2022
Study CompletionJun 2022
TodayJul 2026
First PostedDec 18, 2015
Enrollment StartFeb 23, 2016
Primary CompletionMay 18, 2022
Study CompletionJun 14, 2022
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 10.5 years ago
Interventions
Hypofractionated Radiation Therapyradiation
Treatments will have a minimum of a 48-hour interfraction interval. Treatments will be completed over 20 days maximum.